IL-7 Protein Engineering & Activity Optimization Service
Creative Biolabs' IL-7 protein engineering & activity optimization service provides a targeted, dual-focus approach to cytokine development. We deliver high-performance IL-7 superkines designed with two primary advantages: superior biological potency for robust T-cell stimulation (including memory T cell development) and enhanced folding efficiency for high-yield manufacturing. Clients gain de-risked lead candidates, comprehensive preclinical data packages, and a clear path to generating potent and stable research therapeutics.
Introduction What We Can Offer Workflow Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Engineering IL-7 for Optimized Immune Recovery
IL-7 is fundamental to immune recovery, but its therapeutic potential is limited by rapid clearance and widespread activity. Our service is the solution. We apply structure-guided design to create superkines-variants with enhanced affinity and stability-and leverage half-life extension methods like Fc-fusion. Recent literature confirms that this computational approach is crucial for achieving the dual goal of enhanced folding efficiency and superior immunotherapeutic efficacy in preclinical models, paving the way for safer, more potent research tools.
For an in-depth analysis of how our services can be tailored to your specific project needs, request a consultation.
Fig.1 rhIL-7-hyFc enhances the expansion of UCART19 in vitro and maintains CAR-T polyfunctionality. 1
What We Can Offer
Targeted Superkine Design
Customized engineering of the IL-7 molecule for enhanced receptor affinity and superior biological potency, specifically targeting persistent memory T cell generation.
Tailored PK Extension
Flexible selection and integration of half-life extension modalities, including genetically fused Fc-domains, albumin-binding domains, or site-specific PEGylation, optimized to meet your specific dosing frequency and preclinical research goals.
Custom Toxicity Mitigation
Design and synthesis of conditional Pro-drug cytokine variants that are only activated by specific tumor microenvironment (TME) cues (e.g., protease activity or low pH), ensuring superior selectivity in preclinical models.
How Creative Biolabs' Service Can Assist Your Projects
Why Choose Us?
|
Core Advantages
|
Unique Features
|
|
Computational Design Mastery
|
We are pioneers in using advanced structural biology tools to rationally design mutations that address both affinity and folding efficiency-a crucial and rare dual approach that yields superior superkines.
|
|
De-risking Activity via Selectivity Control
|
We specifically address the pleiotropy of IL-7 by fine-tuning affinity, ensuring maximal memory T cell generation without the non-specific activation that often causes a narrow research window.
|
|
Proven Preclinical & Manufacturing Relevance
|
Our expertise extends to incorporating validated technologies like hybrid Fc-fusion for dramatically extended half-life, ensuring your candidate has a clear path toward advanced preclinical studies.
|
To fully understand the Creative Biolabs advantage, we invite you to get a quote today.
Customer Reviews
-
Superior in vivo performance
Creative Biolabs' superkine strategy provided a cytokine that was instrumental in promoting highly persistent memory T cells. We compared their Fc-fusion construct against a competitor's PEGylated variant and saw a marked increase in T-cell persistence in our animal model, demonstrating superior sustained immune activation. - A. D**s
-
Manufacturing feasibility
The focus on enhanced folding efficiency was a game-changer. Wild-type IL-7 production was cost-prohibitive due to low yield, but Creative Biolabs' computationally guided mutations addressed this directly. We achieved an increase in protein expression yield while maintaining optimal T-cell proliferation activity. - K. Wi**n
FAQs
Q:
How does Creative Biolabs' approach specifically address IL-7's activity limitation and narrow research window?
A:
We use two primary methods. First, we employ Fc-fusion and PEGylation to slow clearance, allowing for lower, less frequent dosing in models. Second, we utilize the prodrug cytokine strategy, where IL-7 is masked and only activated by specific cues (like TME proteases) or low pH conditions found within the tumor microenvironment, minimizing systemic exposure and non-specific effects.
Q:
What is the primary advantage of a computationally designed IL-7 Superkine over a traditional PEGylated IL-7?
A:
A superkine, such as the Neo-7 variant validated in recent research, is engineered for enhanced biological efficacy (higher T-cell proliferation, superior memory T cell generation) and enhanced folding efficiency (better yield). PEGylation only addresses the half-life; our superkine approach addresses half-life, activity, and manufacturability simultaneously.
Related Services
Cytokine Production Measurement Service
Dedicated services for high-throughput screening, ELISA, and customized bioactivity assays (e.g., T-cell proliferation, STAT5 phosphorylation) to precisely quantify the activity and concentration of all cytokine variants.
Learn More →
T Cell Engineering Service
Dedicated services for isolating primary T cells, engineering them with CARs/TCRs, and expanding the modified cell population for subsequent in vivo research.
Learn More →
How to Contact Us
Creative Biolabs delivers IL-7 superkines that are more efficacious, stable, and easier to manufacture for your preclinical studies by coupling advanced computational design with validated PK extension strategies. Ready to accelerate your immunotherapy research project and overcome the limitations of native cytokines? Please contact us.
Reference
-
Kim, Miriam Y et al. "A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity." Nature communications vol. 13,1 3296. 13 Jun. 2022. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41467-022-30860-0
For Research Use Only | Not For Clinical Use
